Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Nu Skin Enterprises is a household & personal products business based in the US. Nu Skin Enterprises shares (NUS) are listed on the NYSE and all prices are listed in US Dollars. Nu Skin Enterprises employs 4,600 staff and has a trailing 12-month revenue of around $2.4 billion.
Finder Award
eToro
Finder Award
SoFi Invest
| Latest market close | $43.77 |
|---|---|
| 52-week range | $29.66 - $54.78 |
| 50-day moving average | $41.04 |
| 200-day moving average | $41.86 |
| Wall St. target price | $39.25 |
| PE ratio | 56.8442 |
| Dividend yield | $1.535 (3.52%) |
| Earnings per share (TTM) | $0.77 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $43.77 from 2023-01-25
| 1 week (2023-01-18) | 6.21% |
|---|---|
| 1 month (2022-12-23) | 5.29% |
| 3 months (2022-10-22) | N/A |
| 6 months (2022-07-26) | 2.87% |
| 1 year (2022-01-26) | -9.13% |
|---|---|
| 2 years (2021-01-26) | -24.64% |
| 3 years (2020-01-24) | 20.21% |
| 5 years (2018-01-26) | 73.43 |
Valuing Nu Skin Enterprises stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nu Skin Enterprises's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nu Skin Enterprises's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Nu Skin Enterprises shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Nu Skin Enterprises's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.35. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nu Skin Enterprises's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nu Skin Enterprises's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $264.7 million.
The EBITDA is a measure of a Nu Skin Enterprises's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.4 billion |
|---|---|
| Operating margin TTM | 8.09% |
| Gross profit TTM | $2 billion |
| Return on assets TTM | 6.43% |
| Return on equity TTM | 4.31% |
| Profit margin | 1.61% |
| Book value | $16.94 |
| Market capitalisation | $2.2 billion |
TTM: trailing 12 months
Dividend payout ratio: 49.52% of net profits
Recently Nu Skin Enterprises has paid out, on average, around 49.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Nu Skin Enterprises shareholders could enjoy a 3.52% return on their shares, in the form of dividend payments. In Nu Skin Enterprises's case, that would currently equate to about $1.535 per share.
While Nu Skin Enterprises's payout ratio might seem fairly standard, it's worth remembering that Nu Skin Enterprises may be investing much of the rest of its net profits in future growth.
Nu Skin Enterprises's most recent dividend payout was on 6 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 22 November 2022 (the "ex-dividend date").
Over the last 12 months, Nu Skin Enterprises's shares have ranged in value from as little as $29.662 up to $54.7804. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nu Skin Enterprises's is 1.1925. This would suggest that Nu Skin Enterprises's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
